News
Dr. Anna Veiga’s project to improve genetic edition of human embryos receives Merck Research Grant
The project aims to develop the CRISPR/Cas9 genetic edition technique in human embryos to study their development
A new platform for the diagnosis of autoimmune encephalitis receives funding from the ERC Proof of Concept grants
The stem cell-based platform would enable a more accurate diagnosis of the disease, as it would detect with high precision a wide range of autoantibodies.
“The research will bring us the knowledge to be able to attack the pandemic” Sebastià Videla
Sebastià tested positive for COVID-19 on March 24, and in this interview, he tells us how he has lived the confinement since then and the reflections he has reached.
Nutrient deficiency in tumor cells attracts cells that suppress the immune system
A study led by IDIBELL researchers and published in the American journal PNAS shows that, by depriving tumor cells of glucose, they release a large number of signaling molecules.
Regulatory pathways unveiled for a key enzyme in retinal photoreceptor cell physiology
Depending on the levels of illumination, the enzyme IMPDH1 is regulated at many levels, allowing to adapt the excitability of the photoreceptors.
The health department will finance 3 IDIBELL’s projects on COVID-19
The projects include new therapies, the use of commercialized drugs for other indications and genetic studies, and some could reach the population before the end of the year.
The IDIBELL and the Bellvitge University Hospital projects are led by the groups of Dr. Jordi Carratalá, Dr. Rafael Mañez, and Dr. Xavier Solanich.
The call has been promoted by the General Directorate of Research and Innovation in Health (DGRI) with the collaboration of AQuAS and Biocat.
A pilot study of the sequencing of the intestinal microbiota establishes the basis for the search of early detection markers of colon cancer
In this pilot study, they used colon biopsies samples and feces samples from nine patients to compare two sequencing methods. It has been defined the appropriate bioinformatic analysis methods for this type of study.
An alternative drug to antibiotics receives the boost from the CaixaImpulse Consolidate program
An alternative to the use of antibiotics created by the group of Dr. Rafael Mañez, from the Bellvitge Biomedical Research Institute (IDIBELL) and the Bellvitge University Hospital (HUB), has been selected by the CaixaImpulse Consolidate program. The project will receive funding of up to 300,000 euros and personalized support in the transfer process to the […]
IDIBELL announces that it will baptize its spaces with the name of world-renowned women scientist
March 8 marks the International Women’s Day. With the aim of giving visibility and vindicating the decisive role that the women scientists have had throughout history, IDIBELL has announced an action in coming weeks. In recent years there have been important organizational changes in the IDIBELL research environment, such as the creation of Research Programs, […]